Anti Bribery & Anti-Corruption Policy

Our Anti-Bribery & Anti-Corruption Policy reaffirms our pledge to conduct business ethically, in full compliance with the US Foreign Corrupt Practices Act (FCPA) and all applicable laws. This commitment extends to every member of our team, our contractors, suppliers, and partners worldwide.

Our Core Principles

01

Zero Tolerance for Bribery & Corruption

We strictly prohibit any form of bribery, kickbacks, facilitation payments, or improper inducements whether offered, given, or received in all business dealings.

02

Transparency in All Interactions

All gifts, hospitality, charitable contributions, and sponsorships must be reasonable, documented, and aligned with ethical business practices never intended to influence decisions.

03

Protection for Those Who Speak Up

We encourage and protect employees and partners who report concerns in good faith. Retaliation against individuals who raise issues or refuse to participate in unethical conduct will not be tolerated.

04

Accountability at Every Level

This policy applies to all employees, directors, contractors, agents, and representatives of Al Mojil Drug Company. Compliance is not optional it is a condition of engagement.

05

Vigilance Through Training & Audits

Regular training, internal audits, and ongoing monitoring ensure our practices remain aligned with our ethical standards and legal obligations.

06

Our promise is clear: we will never compromise our values for commercial gain.

We choose to lead with integrity, to partner with transparency, and to build a legacy of trust—because in healthcare,   there is no room for anything less.